Thuja occidentalis 30C
- Manufacturer
- Boiron | Boiron, Inc.
- Effective date
- 2025-11-21
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-06-01 02:35:21
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient** (in each pellet)
Thuja Occidentalis 30C HPUS (0.443)
The letters "HPUS" indicate that the component in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
OTC - PURPOSE SECTION
Thuja Occidentalis 30C HPUS (0.443) ... For removal of common warts and plantar warts*
INDICATIONS & USAGE SECTION
Uses*
for removal of
- common warts
- plantar warts
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if the discomfort persists or wart becomes painful.
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Adults and children: Dissolve 5 pellets under the tongue 2 times a day, mornings and evenings, until wart is removed or as directed by a doctor.
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
OTC - DO NOT USE SECTION
Do not use if glued carton end flaps are open or if pellet dispenser seal is broken.
Do not use if pellet dispenser seal is broken.
INACTIVE INGREDIENT SECTION
lactose, sucrose
OTC - QUESTIONS SECTION
Boironusa.com
info@boiron.com
1-800-BOIRON-1
1-800-264-7661
Distributed by Boiron Inc.
Newtown Square, PA 19073
SPL UNCLASSIFIED SECTION
*CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED.
**C,K,CK, and X are homeopathic dilutions: see BoironUSA.com/info for details.
Turn tube upside down, twist until 5 pellets are dispensed, Remove cap and pour pellets under the tongue
3 Tubes, Approx. 80 Pellets Each, Total 240 Pellets, 16 Doses per tube
Pain-Free Wart Removal*
No Known Drug Interactions
Common Warts, Plantar Warts*
Wart Removal*
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0220-9356-43 | 2023-04-13 | C162847 | 48780-1 | f386c649-ea73-0266-e053-dadaa90a7c1a | Thuja occidentalis 30C BONUS PACK |
| 0220-9356-43 | 2023-01-30 | C162847 | 48780-1 | f386c649-ea73-0266-e053-dadaa90a7c1a | Thuja occidentalis 30C BONUS PACK |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0220-9356-43 | Thuja occidentalis 30C | 30 [hp_C] in 1 PACKAGE | PELLET | 30 | 5 |
Products#
Every source-derived product name is available through these pages.
- Thuja occidentalis 30C
- THUJA OCCIDENTALIS
- THUJA OCCIDENTALIS LEAFY TWIG
- LACTOSE
- ANHYDROUS LACTOSE
- SUCROSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0220-9356 | 0220-9356-43 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| THUJA OCCIDENTALIS LEAFY TWIG | 1NT28V9397 | ACTIB |
| LACTOSE | J2B2A4N98G | IACT |
| SUCROSE | C151H8M554 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Thuja occidentalis 30C | THUJA OCCIDENTALIS | Boiron | 5e35616f-b057-0f18-e053-2991aa0a5749 | 2025-11-21 | 0220-9356-43 0220-9356 00220935643 441fe92c-ce78-3112-e063-6394a90a7c97 5e35616f-b057-0f18-e053-2991aa0a5749 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.




